Stay updated on MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial
Sign up to get notified when there's something new on the MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial page.

Latest updates to the MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial page
- Check5 days agoChange DetectedThe record history shows a new release version: Revision: v3.5.4 replacing v3.5.3. This indicates a platform update and does not modify the study data or text on the page.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page’s footer updates its ClinicalTrials.gov interface/revision version from v3.5.2 to v3.5.3, indicating a minor site build/version change rather than a study record change.SummaryDifference0.1%

- Check33 days agoChange DetectedAdded revision entry v3.5.2 and removed revision v3.5.0 from the history.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded revision entry v3.5.0 to the history and removed revision v3.4.3.SummaryDifference0.1%

- Check69 days agoChange DetectedA new study record version (v3.4.3) was added to the history, and the previous version (v3.4.2) was removed.SummaryDifference0.1%

- Check98 days agoChange DetectedThe record history shows a new revision (v3.4.2) added and an older revision (v3.4.1) removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial page.